Visualization of a Bruton's Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy. [PDF]
Merchant AS +3 more
europepmc +1 more source
Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review). [PDF]
Lu C +7 more
europepmc +1 more source
Advances in the design and discovery of small-molecule tyrosine kinase inhibitors for breast cancer. [PDF]
Elwaie TA, Aref MMA, Ali HI.
europepmc +1 more source
Inhibition of purine nucleoside and nucleobase transporters by tyrosine kinase inhibitors. [PDF]
Shahid N +5 more
europepmc +1 more source
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. [PDF]
Fearon AE +18 more
europepmc +1 more source
Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors. [PDF]
Padhye V, Ho J.
europepmc +1 more source
Control of Schwann Cell Myelination by DDR1 Receptor Tyrosine Kinase. [PDF]
Fan M +6 more
europepmc +1 more source
Repurposing Tyrosine Kinase Inhibitors for Sickle Cell Disease: Focus on Band 3 Phosphorylation. [PDF]
Gupta R +3 more
europepmc +1 more source
The role of tyrosine kinase inhibitors as a post-hematopoietic stem cell transplant continuation therapy for pediatric acute leukemia: a systematic review. [PDF]
Avineni M +4 more
europepmc +1 more source

